MedTrace Logo MedTrace
Clinical Trials News Drugs Diseases Companies About

Biogen

  1. Home
  2. Companies
  3. Biogen
  4. Clinical Trials

Clinical Trials Related to Biogen

Related studies linked through entity extraction aliases.

NCT00032786

Safety and Efficacy of Natalizumab in the Treatment of Crohn's Disease

Status
COMPLETED
Phase
PHASE3

NCT00031642

Monoclonal Antibody Therapy in Relapsed Non-Hodgkin's After Chemotherapy and Autologous Stem Cell Transplantation

Status
COMPLETED
Phase
PHASE1/PHASE2

NCT00031083

Dose Escalation Study to Determine the Safety of IFN-Beta Gene Transfer in the Treatment of Grade III & Grade IV Gliomas

Status
COMPLETED
Phase
PHASE1

NCT00030966

Safety and Efficacy of Natalizumab in Combination With Avonex in the Treatment of Multiple Sclerosis

Status
COMPLETED
Phase
PHASE3

NCT00027300

Safety and Efficacy of Natalizumab in the Treatment of Multiple Sclerosis

Status
COMPLETED
Phase
PHASE3

NCT00005592

Radioimmunotherapy in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma

Status
COMPLETED
Phase
PHASE2

NCT00000721

An Escalating Dose Tolerance Trial of BG8962 (rCD4) in Patients Who Are HIV Antibody Positive

Status
COMPLETED
Phase
PHASE1

NCT00000659

A Phase II Trial of rsCD4 and AZT in Patients With AIDS or Advanced AIDS Related Complex (ARC)

Status
TERMINATED
Phase
PHASE2
Previous

Next

Clinical Trials

Explore studies by the year of their last update.

  • 2026
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005

News & Analysis

Latest news and insights on clinical trials and medical research.

Browse All News →
MedTrace Logo MedTrace
About Privacy Policy Terms of Service Medical Disclaimer

© 2026 MedTrace.
Open-access medical & pharmaceutical data intelligence.